Variant alleles of VEGF and risk of esophageal cancer and lymph node metastasis

References

• Balasubramanian SP, Cox A, Cross SS, et al. (2007). Influence of vegf-a gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 121:1009–16
   PubMed Web of Science ®Google Scholar
• Bradbury PA, Zhai R, Ma C, et al. (2009). Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res 15:4680–5
   PubMed Web of Science ®Google Scholar
• Brogan IJ, Khan N, Isaac K, et al. (1999). Novel polymorphisms in the promoter and 5′ utr regions of the human vascular endothelial growth factor gene. Hum Immunol 60:1245–9
   PubMed Web of Science ®Google Scholar
• Cacev T, Loncar B, Seiwerth S, et al. (2008). Vascular endothelial growth factor polymorphisms −1154 g/a and −460 c/t are not associated with vegf mrna expression and susceptibility to sporadic colon cancer. DNA Cell Biol 27:569–74
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature 407:249–57
   PubMed Web of Science ®Google Scholar
• Clar H, Krippl P, Renner W, et al. (2009). Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 113:197–8
   PubMedGoogle Scholar
• Cook MB, Dawsey SM, Freedman ND, et al. (2009). Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18:1174–82
   PubMed Web of Science ®Google Scholar
• Dassoulas K, Gazouli M, Rizos S, et al. (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563–9
   PubMed Web of Science ®Google Scholar
• Eroglu A, Ozturk A, Cam R, et al. (2008). Vascular endothelial growth factor gene 936 c/t polymorphism in breast cancer patients. Med Oncol 25:54–5
   PubMed Web of Science ®Google Scholar
• Ferrara N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611
   PubMed Web of Science ®Google Scholar
• Foley R, Marignol L, Thomas AZ, et al. (2009). The hif-1alpha c1772t polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther 8:118–24
   PubMed Web of Science ®Google Scholar
• Giacalone A, Montalto G, Giannitrapani L, et al. (2011). Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-alpha, and vascular endothelial growth factor-a genes, and susceptibility to hepatocellular carcinoma. Omics 15:193–6
   PubMedGoogle Scholar
• Gu H, Ding G, Zhang W, et al. (2012). Replication study of plce1 and c20orf54 polymorphism and risk of esophageal cancer in a chinese population. Mol Biol Rep 39:9105–11
   PubMed Web of Science ®Google Scholar
• Hofmann G, Langsenlehner U, Renner W, et al. (2008). Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 134:591–5
   PubMed Web of Science ®Google Scholar
• Hsiao PJ, Lu MY, Chiang FY, et al. (2007). Vascular endothelial growth factor gene polymorphisms in thyroid cancer. J Endocrinol 195:265–70
   PubMed Web of Science ®Google Scholar
• Inoue K, Ozeki Y, Suganuma T, et al. (1997). Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 79:206–13
   PubMed Web of Science ®Google Scholar
• Kim DH, Lee NY, Lee MH, et al. (2008a). Vascular endothelial growth factor (vegf) gene (vegfa) polymorphism can predict the prognosis in acute myeloid leukaemia patients. Br J Haematol 140:71–9
   PubMed Web of Science ®Google Scholar
• Kim JG, Chae YS, Sohn SK, et al. (2008b). Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62–6
   PubMed Web of Science ®Google Scholar
• Kim JS, Yim SV, Koh IS, et al. (2009). Single-nucleotide polymorphisms (snps) and haplotype analysis in vascular endothelial growth factor (vegf) gene in the patients with parkinson disease and lung cancer. Arch Gerontol Geriatr 48:287–90
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim MA, Park IA, et al. (2010). Vegf polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecol Oncol 119:232–6
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Papazoglou D, Giatromanolaki A, et al. (2004). Vegf gene sequence variation defines vegf gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293–8
   PubMed Web of Science ®Google Scholar
• Langsenlehner T, Langsenlehner U, Renner W, et al. (2008). Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. Eur J Cancer 44:1572–6
   PubMed Web of Science ®Google Scholar
• Layke JC, Lopez PP. (2006). Esophageal cancer: a review and update. Am Fam Physician 73:2187–94
   PubMed Web of Science ®Google Scholar
• Li R, Zhao Y, Fan W, et al. (2011). Possible association between polymorphisms of human vascular endothelial growth factor a gene and susceptibility to glioma in a chinese population. Int J Cancer 128:166–75
   PubMedGoogle Scholar
• Li Y, Wang Y, Kang S, et al. (2010). Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. Int J Gynecol Cancer 20:717–23
   PubMed Web of Science ®Google Scholar
• Liu JF, Wang QZ, Hou J. (2004). Surgical treatment for cancer of the oesophagus and gastric cardia in hebei, china. Br J Surg 91:90–8
   PubMedGoogle Scholar
• Lu H, Shu XO, Cui Y, et al. (2005). Association of genetic polymorphisms in the vegf gene with breast cancer survival. Cancer Res 65:5015–19
   PubMed Web of Science ®Google Scholar
• Makrilia N, Lappa T, Xyla V, et al. (2009). The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 20:663–71
   PubMed Web of Science ®Google Scholar
• Niu G, Chen X. (2010). Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets 11:1000–17
   PubMed Web of Science ®Google Scholar
• Polterauer S, Grimm C, Mustea A, et al. (2007). Vascular endothelial growth factor gene polymorphisms in ovarian cancer. Gynecol Oncol 105:385–9
   PubMedGoogle Scholar
• Qiu LX, Wang K, Yang S, et al. (2011). Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Mol Biol Rep 38:4491–4
   PubMedGoogle Scholar
• Saenz-Lopez P, Vazquez F, Cozar JM, et al. (2013). Vegf polymorphisms are not associated with an increased risk of developing renal cell carcinoma in spanish population. Hum Immunol 74:98–103
   PubMedGoogle Scholar
• Sakaeda T, Yamamori M, Kuwahara A, et al. (2008). Vegf g-1154a is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in japanese patients. Ther Drug Monit 30:497–503
   PubMedGoogle Scholar
• Schneider BP, Radovich M, Flockhart DA, et al. (2009). Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. Breast Cancer Res Treat 116:543–9
   PubMedGoogle Scholar
• Stevens A, Soden J, Brenchley PE, et al. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812–16
   PubMed Web of Science ®Google Scholar
• Uchida S, Shimada Y, Watanabe G, et al. (1998). In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 77:1704–9
   PubMed Web of Science ®Google Scholar
• Vancleave TT, Moore JH, Benford ML, et al. (2010). Interaction among variant vascular endothelial growth factor (vegf) and its receptor in relation to prostate cancer risk. Prostate 70:341–52
   PubMed Web of Science ®Google Scholar
• Vincenti V, Cassano C, Rocchi M, et al. (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493–5
   PubMed Web of Science ®Google Scholar
• Wang T, Hu K, Ren J, et al. (2010). Polymorphism of vegf-2578c/a associated with the risk and aggressiveness of nasopharyngeal carcinoma in a chinese population. Mol Biol Rep 37:59–65
   PubMedGoogle Scholar
• Xing D, Tan W, Lin D. (2003). Genetic polymorphisms and susceptibility to esophageal cancer among chinese population (review). Oncol Rep 10:1615–23
   PubMed Web of Science ®Google Scholar
• Yapijakis C, Vairaktaris E, Vassiliou S, et al. (2007). The low vegf production allele of the +936c/t polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133:787–91
   PubMedGoogle Scholar
• Zhai R, Liu G, Asomaning K, et al. (2008a). Genetic polymorphisms of vegf, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 29:2330–4
   PubMedGoogle Scholar
• Zhai R, Liu G, Zhou W, et al. (2008b). Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res 14:612–17
   PubMed Web of Science ®Google Scholar
• Zhang W, Bailey-Wilson JE, Li W, et al. (2000). Segregation analysis of esophageal cancer in a moderately high-incidence area of northern china. Am J Hum Genet 67:110–19
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li N, Zhuang W, et al. (2011). Vascular endothelial growth factor (vegf) gene polymorphisms and gastric cancer risk in a chinese han population. Mol Carcinog 50:184–8
   PubMedGoogle Scholar